On Friday, Ford Motor Company (NYSE:F)’s shares declined -0.34% to $14.52.
F has 60.00% institutional ownership while its EPS ratio was 1.19. The company has 3.90 billion shares outstanding while market capitalization of the company was $57.62 billion. Price to book ratio was 2.10. Net profit margin of the company was 3.30% while gross profit margin was 14.30%. Stock volatility for the month was booked as 1.29% while for the week was recorded as 1.67%.
The mean estimate for the short term price target for Ford Motor Company (NYSE:F) stands at $17.65 according to 17 Analysts. The higher price target estimate for the stock has been calculated at $22.00 while the lower price target estimate is at $15.00.
Analysts mean recommendation for the stock is 2.50. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Ford Motor Company (Ford) manufactures or distributes automobiles across six continents. The Company operates in two sectors: Automotive and Financial Services. Automotive sector includes North America, South America, Europe, Middle East & Africa, and Asia Pacific segments. Financial Services sector includes Ford Motor Credit Company and Other Financial Services segments.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s shares gained 3.82% to $81.78.
VRX Its past 5-day performance at -26.66%. So far in 2015, the company has a year-to-date performance of -42.86%. The stock, as of last close, traded 11.52% up from its 52 week low and was -69.00% below its 52 week high. Its latest closing price was -60.32% below the SMA200 while the distance from SMA 50 and SMA 20 was -54.13% and -37.25% respectively.
The mean estimate for the short term price target for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stands at $52.38 according to 4 Analysts. The higher price target estimate for the stock has been calculated at $75.00 while the lower price target estimate is at $34.50.
Analysts mean recommendation for the stock is 3.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over 100 countries.
At the end of Friday’s trade, Expedia Inc (NASDAQ:EXPE)‘s shares dipped -2.91% to $133.32.
EXPE has market capitalization of $17.31 billion. Its current ratio was -0.80 while its shares were above its 50 days simple moving average with 8.34%. The company offered earning per share of $6.34 while its 117.01 million shares were outstanding. YTD performance of the company was 56.19%. Stock volatility for the week was 3.50% while for the month it was shown at 3.16%.
The mean estimate for the short term price target for Expedia Inc (NASDAQ:EXPE) stands at $148.83 according to 24 Analysts. The higher price target estimate for the stock has been calculated at $180.00 while the lower price target estimate is at $107.00.
Analysts mean recommendation for the stock is 2.40. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Expedia, Inc. (Expedia) is an online travel company. The Company provides travel products and services provided by various lodging properties, airlines, car rental companies, destination service providers, cruise lines and other travel product and service companies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.